Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AUPH · as of Jun 8, 2026
Key Statistics
Explore Aurinia Pharmaceuticals Inc. Data
auph stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 78.6%
The AUPH analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $12.60, representing -20.45% downside from the current price of $15.84.
Competitors & Peers
auph competitorsAUPH
ABCL
BHVN
CLDX
HRMY
IMCRStock Performance
Full HistoryAbout Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States a…
what is aurinia pharmaceuticals inc. · auph stock overview · aurinia pharmaceuticals inc. company profile · who is aurinia pharmaceuticals inc. ceo · auph NASDAQ · aurinia pharmaceuticals inc. headquarters · aurinia pharmaceuticals inc. business segments
About Stock Overview & Key Data
Aurinia Pharmaceuticals Inc. (AUPH) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 3, 2014. As of the latest trading session, AUPH stock price is $15.84, with a market capitalization of $2.0B. The stock has returned +94.59% over the past 12 months and -0.69% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Aurinia Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $12.60. In fiscal year 2025, Aurinia Pharmaceuticals Inc. reported revenue of $283.1M and net income of $287.2M. For detailed data — including Aurinia Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aurinia Pharmaceuticals Inc. (AUPH) stock price is $15.84. The stock is traded on NASDAQ under the ticker symbol AUPH. The 52-week range is $7.29 – $16.88.